GlassScriptPhysician profile
Brittany D Carter-Snell
NPI 1952613168
$2,119.97
in general payments reported to CMS, 2019-2025
23 companies · $1,420 in 2025
The $1,420 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2022: $13.94 · 2023: $165 · 2024: $365 · 2025: $1,420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,896 · Education: $53.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,896.07 |
| Education | $53.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $331.09 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $219.23 | 2024-2025 | Zoryve |
| Organon LLC | $208.12 | 2025 | Vtama |
| Incyte Corporation | $157.00 | 2023-2024 | Opzelura |
| Genzyme Corporation | $151.75 | 2022-2025 | |
| Janssen Biotech, INC. | $133.67 | 2023-2025 | Tremfya, Rybrevant |
| Pfizer INC. | $129.13 | 2019-2025 | |
| Ucb, INC. | $106.91 | 2025 | Bimzelx |
| Allergan, INC. | $97.33 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $95.38 | 2024-2025 | Dupixent, Libtayo |
| Solta Medical, A Division of Bausch Health US, LLC | $85.32 | 2019-2025 | Clear+Brilliant |
| Galderma Laboratories, L.P. | $54.01 | 2025 | Nemluvio, Aklief |
| Leo Pharma INC. | $49.17 | 2025 | Anzupgo, Adbry |
| Sun Pharmaceutical Industries INC. | $44.52 | 2025 | |
| Medline Industries LP | $44.49 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $43.47 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $39.14 | 2024 | Sotyktu |
| Botanix Sb INC | $38.50 | 2025 | Sofdra |
| Lilly USA, LLC | $25.50 | 2025 | Taltz, Ebglyss |
| Journey Medical Corporation | $22.40 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.20 | 2025 | Siliq, Jublia, Cabtreo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.00 | 2019 | |
| Taro Pharmaceuticals USA, INC. | $12.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Carter-Snell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.